Rafael Pharmaceuticals

About:

Rafael Pharmaceuticals is clinical-stage, metabolic oncology therapeutics company.

Website: https://rafaelpharma.com/

Twitter/X: RafaelPharma

Top Investors: Chetrit Ventures, IDT Corporation, Althea Partners

Description:

Rafael Pharmaceuticals is a provider of metabolic oncology therapeutics intended to treat cancer patients. The company's metabolic oncology therapeutics applies unique bio-energetic processes specific to cancer and provide altered cancer metabolism directed therapies and novel, first-in-class drugs and drug delivery technologies, enabling patients to get revolutionized cancer treatment.

Total Funding Amount:

$35.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cranbury, New Jersey, United States

Founded Date:

2000-01-01

Contact Email:

info(AT)rafaelpharma.com

Founders:

David A. Polinsky, Robert Shorr

Number of Employees:

11-50

Last Funding Date:

2016-11-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai